Ampio Pharm Valuation
| AMPEDelisted Stock | USD 0.24 0.01 4.35% |
Ampio Pharm seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Ampio Pharm from analyzing the firm fundamentals such as Shares Owned By Insiders of 1.56 %, return on equity of -1.14, and Current Valuation of (3.33 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ampio Pharm's price fluctuation is very steady at this time. Calculation of the real value of Ampio Pharm is based on 3 months time horizon. Increasing Ampio Pharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ampio pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Ampio Pharm. Since Ampio Pharm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ampio Pink Sheet. However, Ampio Pharm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.24 | Real 0.21 | Hype 0.24 | Naive 0.22 |
The real value of Ampio Pink Sheet, also known as its intrinsic value, is the underlying worth of Ampio Pharm Company, which is reflected in its stock price. It is based on Ampio Pharm's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ampio Pharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ampio Pharm helps investors to forecast how Ampio pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ampio Pharm more accurately as focusing exclusively on Ampio Pharm's fundamentals will not take into account other important factors: Ampio Pharm Total Value Analysis
Ampio Pharm is presently projected to have valuation of (3.33 M) with market capitalization of 340.61 K, debt of 274 K, and cash on hands of 23.25 M. The negative valuation of Ampio Pharm may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Ampio Pharm fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(3.33 M) | 340.61 K | 274 K | 23.25 M |
Ampio Pharm Asset Utilization
One of the ways to look at asset utilization of Ampio is to check how much profit was generated for every dollar of assets it reports. Ampio Pharm shows a negative utilization of assets of -0.62 percent, losing $0.006157 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Ampio Pharm shows how discouraging it operates for each dollar spent on its assets.Ampio Pharm Ownership Allocation
Almost 94.25 percent of Ampio Pharm outstanding shares are held by general public with 1.56 (percent) owned by insiders and only 4.19 % by other corporate entities.Ampio Pharm Profitability Analysis
Net Loss for the year was (8.63 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ampio Pharm's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ampio Pharm and how it compares across the competition.
About Ampio Pharm Valuation
The pink sheet valuation mechanism determines Ampio Pharm's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ampio Pharm. We calculate exposure to Ampio Pharm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ampio Pharm's related companies.Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19 and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. Ampio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 18 people.
8 Steps to conduct Ampio Pharm's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ampio Pharm's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ampio Pharm's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ampio Pharm's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ampio Pharm's revenue streams: Identify Ampio Pharm's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ampio Pharm's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ampio Pharm's growth potential: Evaluate Ampio Pharm's management, business model, and growth potential.
- Determine Ampio Pharm's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ampio Pharm's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ampio Pharm Growth Indicators
Investing in growth stocks can be very risky. If the company such as Ampio Pharm does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 810.1 K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |